Institutional Review Board
Board that reviews and approves human-subjects research at an institution.
Definition
An IRB is a committee that reviews biomedical research involving human subjects to ensure their rights and welfare are protected, per 21 CFR Part 56. Under 21 CFR Part 56, an IRB must have at least five members with varied backgrounds, including one non-scientist and one member not affiliated with the institution. It approves, requires changes to, or disapproves studies, reviews informed consent, conducts continuing review, and for device studies decides whether a study is significant or non-significant risk. In the EU the equivalent body is an ethics committee.What this means in practice
Both SR and NSR device studies require IRB approval. Non-U.S. trials use equivalent ethics committees.Examples
- A MedTech company developing a new cardiac stent must submit its clinical investigation plan, including the informed consent form and patient recruitment materials, to an IRB for approval before enrolling any patients.
- A medical device manufacturer conducting a post-market surveillance study involving patient surveys must obtain IRB clearance, even if the data collected is de-identified, to ensure ethical considerations are met.
- A researcher modifying a previously approved study protocol to include a new patient population or a different data collection method must submit an amendment to the IRB for review and authorization prior to implementing the changes.
- •Failing to obtain IRB approval before initiating a clinical investigation can lead to regulatory non-compliance and invalidation of study data.
- •Misinterpreting the scope of IRB review, assuming it only applies to interventional studies and not to observational studies or studies using existing de-identified data, is a common pitfall.
- •Not ensuring that all investigators and research staff have completed appropriate human subjects protection training can result in IRB findings and study delays.
- •Neglecting to submit modifications to an approved study protocol to the IRB for review and approval prior to implementation can be a serious regulatory violation.
- •Assuming that an IRB approval from one institution is automatically transferable to another without formal review and acceptance by the second institution's IRB is incorrect and can lead to unapproved research activities.
Frequently asked questions
Cross-references
Uses
Related terms
Grouped by themeEditor's picks
· Hand-selected related conceptsClinical Trials & Evidence
· From this learning pathAnnual report sponsors must submit to FDA summarizing the progress of an approved IDE study, including enrollment, deviations, and adverse events.
Trial design that pre-specifies opportunities to modify aspects (sample size, arms, endpoints) based on interim data.
Any untoward medical occurrence in a subject, whether or not related to the device.
Documented assessment of clinical data demonstrating EU MDR conformity for a device.
More in Clinical & Trials
· Same categoryWhere this term appears across MedTech Terms.
- Clinical Trials & EvidenceLesson 4 of 18
Latest in MedTech
Sources
3 sourcesEvery citation below opens the original document. Each is graded against our source-tier hierarchy so you can see what rests on binding law versus commentary.
- 121 CFR Part 56Tier 1 VerifiedeCFRecfr.gov
- 2ICH GuidelinesTier 2 VerifiedICHich.org
- 3ISO 14155 Standard PageTier 1 VerifiedISOiso.org
Inline markers like [1] jump to the matching reference above.